Literature DB >> 21459789

The natural occurrence of human fibrinogen variants disrupting inter-chain disulfide bonds (A{alpha}Cys36Gly, A{alpha}Cys36Arg and A{alpha}Cys45Tyr) confirms the role of N-terminal A{alpha} disulfide bonds in protein assembly and secretion.

Michel Hanss1, Catherine Pouymayou, Marie-Thérèse Blouch, Franck Lellouche, Patrick Ffrench, Robert Rousson, Jean-François Abgrall, Pierre-Emmanuel Morange, Florence Quélin, Philippe de Mazancourt.   

Abstract

Analyses of site-directed fibrinogen mutants expressed in several recombinant models have previously shown that both inter- and intra-chain disulfide bonds are critical for fibrinogen assembly and secretion. Four naturally occurring mutations on AαCys36 and AαCys45 residues are reported here to be associated with decreased fibrinogen levels. This confirms the main role of the AαCys36-BβCys65 and AαCys45-γCys23 disulfide bonds in reaching a normal fibrinogen plasma level. Decreased coagulant/antigen ratios indicate abnormal species secretion in heterozygous subjects which varies between individuals. However, in contrast to overexpression in experimental models, disruption of the AαCys36-BβCys65 disulfide bond did not result in the appearance of Aα-Bβ-γ moieties in vivo. A 188 kDa molecule reacting only with anti Aα and anti Bβ chains was found in the plasma of the AαCys45Tyr variant. Heterozygous carriers of Aα chain mutations usually have normal fibrinogen levels, in contrast to the AαCys36Gly, AαCys36Arg and AαCys45Tyr variants that are shown here to cause hypofibrinogenemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459789      PMCID: PMC3148918          DOI: 10.3324/haematol.2010.029801

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  20 in total

1.  THE PREPARATION AND SOME PROPERTIES OF FIBRINOGEN PRECIPITATED FROM HUMAN PLASMA BY GLYCINE.

Authors:  L A KAZAL; S AMSEL; O P MILLER; L M TOCANTINS
Journal:  Proc Soc Exp Biol Med       Date:  1963 Aug-Sep

2.  Crystal structure of the complex between thrombin and the central "E" region of fibrin.

Authors:  Igor Pechik; Joel Madrazo; Michael W Mosesson; Irene Hernandez; Gary L Gilliland; Leonid Medved
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

3.  Fibrinogen assembly and secretion. Role of intrachain disulfide loops.

Authors:  J Z Zhang; C Redman
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

4.  Fibrinogen Montreal: a novel missense mutation (Aa D496N) associated with hypofibrinogenaemia.

Authors:  Campbell R Sheen; Stephen O Brennan; Nada Jabado; Peter M George
Journal:  Thromb Haemost       Date:  2006-08       Impact factor: 5.249

Review 5.  The molecular basis of quantitative fibrinogen disorders.

Authors:  R Asselta; S Duga; M L Tenchini
Journal:  J Thromb Haemost       Date:  2006-10       Impact factor: 5.824

Review 6.  Fibrinogen and fibrin structure and functions.

Authors:  M W Mosesson
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

7.  Symmetrical disulfide bonds are not necessary for assembly and secretion of human fibrinogen.

Authors:  J Z Zhang; B Kudryk; C M Redman
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

8.  Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen.

Authors:  J Z Zhang; C M Redman
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

9.  Two novel fibrinogen variants found in patients with pulmonary embolism and their families.

Authors:  M M L Hanss; P O Ffrench; J F Mornex; M Chabuet; F Biot; P De Mazancourt; M Dechavanne
Journal:  J Thromb Haemost       Date:  2003-06       Impact factor: 5.824

10.  A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I.

Authors:  K Niwa; M Takebe; T Sugo; Y Kawata; J Mimuro; S Asakura; Y Sakata; J Mizushima; A Maeda; H Endo; M Matsuda
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

View more
  4 in total

1.  Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia.

Authors:  Zhilian Hu; Kari I Lavik; Yang Liu; Andy H Vo; Catherine E Richter; Jorge Di Paola; Jordan A Shavit
Journal:  J Thromb Haemost       Date:  2019-02-25       Impact factor: 5.824

Review 2.  Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish.

Authors:  Azhwar Raghunath; Allison C Ferguson; Jordan A Shavit
Journal:  Res Pract Thromb Haemost       Date:  2022-08-05

3.  Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria.

Authors:  Soraya Hadjali-Saichi; Philippe de Mazancourt; Jacqueline Tapon-Bretaudière; Tristan Mirault; Kahina Guenounou; Issam Frigaa; Anne-Marie Fischer; Ouerdia Chafa; Dominique Helley
Journal:  Haemophilia       Date:  2022-04-30       Impact factor: 4.263

4.  A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.

Authors:  Chiaki Taira; Kazuyuki Matsuda; Shinpei Arai; Mitsutoshi Sugano; Takeshi Uehara; Nobuo Okumura
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.